MOREPENLAB:

After a good result and a strong chart pattern, we can expect some good moves in Morepen Labs.

MOREPENLAB:

After a strong result and a good pattern on charts, morepen looks good for a long position.

MOREPENLAB:

Morepen Labs - 19 yrs BO - excellent fundamentals new 100Mil$ investment good productline

MOREPENLAB:

Morepen Lab is going to break All 9 years record of sales and net profit this financial year And also sales and net profit is increased every year ..

MOREPENLAB:

Good long expected.

MOREPENLAB:

Resistance Breakout Retest complete. NSE:MOREPENLAB

MOREPENLAB:

Looking for a breakout and a target of 45

MOREPENLAB:

Need time to proof

MOREPENLAB:

bought small... will watch how candle is closing and may add if it is closing strong sl dcb

MOREPENLAB:

On breakout, target expectation of 40

MOREPENLAB:

MOREPENLAB DAILY CHART 1. SYMMETRICAL TRIANGLE 2. CUP & HANDLE

MOREPENLAB:

Guys, MORRPENLAB completed 4th wave, now started 5th wave.. Buy and sell after 20..30% profit

MOREPENLAB:

Morepen Lab Technical indicator shows that it hits the Channel Up. Big Volume can be noticed, as its manufacturing PPE which are in high demand due to COVID19.

Valuation

Enterprise Value/EBITDA, TTM —

Enterprise Value, FQ —

Market Cap — Basic —

Number of Employees —

Number of Shareholders —

Price/Earnings, TTM —

Price/Revenue, TTM —

Price/Book Ratio, FY —

Price/Sales Ratio, FY —

Balance Sheet

Current Ratio, FQ —

Debt to Equity, FQ —

Net Debt, FQ —

Quick Ratio, FQ —

Total Assets, FQ —

Total Debt, FQ —

Operating Metrics

Return on Assets, TTM —

Return on Equity, TTM —

Return on Invested Capital, TTM —

Revenue per Employee, TTM —

Price History

Average Volume (10 day) —

Beta - 1 Year —

Price - 52 Week High —

Price - 52 Week Low —

Dividends

Dividends Paid, FY —

Dividends per Share, FY —

Expected Annual Dividends —

Dividends Yield —

Margins

Net Margin, TTM —

Gross Margin, TTM —

Operating Margin, TTM —

Pretax Margin, TTM —

Income Statement

Basic EPS, Net Income —

Earnings per Share, Basic, TTM —

EBITDA, TTM —

Gross Profit, FY —

Last Annual EPS —

Last Annual Revenue, FY —

Net Income, FY —

Total Revenue, FY —

Free Cash Flow, TTM —

More financials

Profile

Sector: Health Technology

Industry: Pharmaceuticals: Other

Morepen Laboratories Ltd. engages in the manufacture and market of bulk drugs and pharmaceutical formulations. It operates through the following business segments: Active Pharmaceutical Ingredients, Formulations, HomeHealth and Dr. Morepen. The company was founded by K.B. Suri on December 1, 1984 and is headquartered in New Delhi, India.

News

Write us

Find us at the office

Blotner- Kwas street no. 55, 39246 Canberra, Australia

Give us a ring

Dymon Rothfuss
+78 715 483 676
Mon - Fri, 10:00-22:00

Write us